Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ATKJ:US

0.0020 USD 0.00000.00%

As of 20:10:02 ET on 03/24/2015.

Company Profile for Artec Inc/NV (ATKJ)

Artec, Inc. is seeking to manufacture, distribute, and market TUBERCIN in the United States and Canada. The Company's product strenghtens the immune system to eradicate various types of cancer in patients without any side effects.

Contact Information

Artec Inc/NV

5960 South Highland Drive
Suite 255
Sacramento, CA 95822
United States
Phone: 1-405-949-1808

Key Executives for Artec Inc/NV (ATKJ)

Ronald ShinnChairmanGerry G KnightExec VP/Coordinator:Funds
George E Williams JrDirectorCecil ThompsonCoordinator:Bahamas
Rodney WatsonCoordinator:South Africa

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil